Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Free Cash Flow Generation Index
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Free Cash Flow Generation Index of 0.72x as of December 2024. Free cash flow of CN¥83.22 Million represents 1% of operating cash flow (CN¥116.38 Million). Explore 301033 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Medprin Regenerative Medical Technologies Co. Ltd. Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. For the full cash flow conversion analysis, see Medprin Regenerative Medical Technologie operating cash flow efficiency.
Annual Free Cash Flow Generation for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year Free Cash Flow Generation Index for Medprin Regenerative Medical Technologies Co. Ltd.. Check Medprin Regenerative Medical Technologie (301033) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.72x | CN¥83.22 Million | CN¥116.38 Million | CN¥33.16 Million | ▲ +13.9% |
| 2023 | 0.63x | CN¥67.60 Million | CN¥107.69 Million | CN¥40.09 Million | ▲ +134.6% |
| 2022 | -1.81x | CN¥-87.65 Million | CN¥48.31 Million | CN¥135.96 Million | ▼ -40.0% |
| 2021 | -1.30x | CN¥-86.20 Million | CN¥66.51 Million | CN¥152.71 Million | ▼ -58.4% |
| 2020 | -0.82x | CN¥-27.74 Million | CN¥33.91 Million | CN¥61.65 Million | ▼ -370.6% |
| 2019 | -0.17x | CN¥-5.44 Million | CN¥31.27 Million | CN¥36.71 Million | — |